The ImmuBridge™ platform embodies cutting-edge advancements in oncology and immunotherapy. Leveraging this platform, we can develop trispecific antibodies targeting a variety of immune and tumor cell antigens to activate diverse immune mechanisms, fostering precise and efficient cancer therapeutics.
Create New Offer
Report this Page
Rate Trispecific Antibody Development
Create Job
Edit Offer
Add tier
Delete your tier
Are you sure you want to delete this tier?
Reviews
In order to sell your content and posts, start by creating a few packages. Monetization
Pay By Wallet
Payment Alert
You are about to purchase the items, do you want to proceed?
